The document discusses intellectual property rights as they relate to the pharmaceutical industry. It defines intellectual property rights as statutory rights that grant creators exclusive commercial exploitation of their work for a period of time. The document outlines various types of intellectual property protections including patents, trademarks, copyrights, industrial designs, geographical indications, and trade secrets. It provides examples of how these intellectual property rights are applied within the pharmaceutical industry.